PUBLISHER: TechSci Research | PRODUCT CODE: 1770815
PUBLISHER: TechSci Research | PRODUCT CODE: 1770815
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Single-Use Bioreactors (SUBs) Market was valued at USD 2.30 billion in 2024 and is projected to reach USD 4.75 billion by 2030, growing at a CAGR of 12.85% during the forecast period. The market's growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 2.30 Billion |
Market Size 2030 | USD 4.75 Billion |
CAGR 2025-2030 | 12.85% |
Fastest Growing Segment | Gene Modified Cells |
Largest Market | North America |
For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen-demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.
Key Market Drivers
Surge in Biopharmaceutical Demand and Biosimilar Production
The growing demand for biopharmaceutical products-particularly monoclonal antibodies, vaccines, and biosimilars-is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.
Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.
Key Market Trends
Integration of Digital Technologies in Bioprocessing
The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control-enhancing efficiency, product quality, and compliance.
Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.
In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.
Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: